Kidney Beam Joins DigitalHealth.London Accelerator Programme 

Today Kidney Beam is proud to announce they are one of the 17 digital health companies selected for DigitalHealth.London’s Accelerator programme. The companies selected for the Accelerator 2023/24 programme have digital solutions or services that have the highest potential to meet London’s NHS and social care challenges.

Now in its seventh consecutive year, the DigitalHealth.London Accelerator is funded by Health Innovation Network (HIN) through its Office for Life Sciences funding and its partners, including CW+. In addition, the Accelerator will receive £185k from the UK Government through the UK Shared Prosperity Fund for some aspects of this programme.

Sara Nelson, Programme Director, DigitalHealth.London, said: “We are delighted to announce the 17 digital health companies joining our seventh DigitalHealth.London Accelerator cohort. The application process for this year’s programme was extremely competitive and as such, the final 17 companies truly are the ones to watch in the digital health space. We look forward to working with them over the next year to support the NHS and social care through digital transformation.” 

Katie Bell, CEO, Kidney Beam, said: "The DigitalHealth.London accelerator comes at an exciting point in our company’s trajectory, with the positive results of our clinical trial being announced last month, our fundraising round soon to launch and 5 successful NHS implementations under our belts. The programme will be invaluable in supporting us to gain further adoption throughout the NHS and expand our network, alongside 16 other inspiring start-ups doing some really important work in the digital health space." 

DigitalHealth.London’s Accelerator aims to speed up the adoption of technology in London’s NHS, relieving high pressure on services and empowering patients to manage their health. The Accelerator has previously supported 143 high potential digital health companies across six cohorts. It works with the companies over a 12-month period, giving bespoke support and advice, a programme of expert-led workshops and events, and brokering meaningful connections between innovators and NHS organisations with specific challenges. The companies successful in getting onto the Accelerator programme have been chosen through a rigorous and highly competitive selection process, involving expert NHS and industry panel assessments, interviews, and due diligence checks. 

For more information about each company visit: https://digitalhealth.london/cohort-7-accelerator

Previous
Previous

Physiotherapists in Newcastle Livestream Kidney Beam for Patients on their Ward

Next
Next

Kidney Beam now clinically proven to improve health related quality of life of kidney disease patients through ground-breaking research trial